Alliance Growers Corp.(CSE:ACG; FWB:1LA) is pleased to announce that the Company and its business partner, Botanical Research in Motion Inc. (“BRIM”), are in the preliminary stages of preparing for an Access to Cannabis for Medical Purposes Regulations (“ACMPR”) application with Health Canada, now that the offer to purchase the property for the Cannabis Botany Centre has been accepted. The purchase will close on September 5, 2017 and immediately thereafter BRIM and Alliance Growers will work together to complete the ACMPR application.
The ACMPR Application will initially be for the 40,000 square foot Cannabis Botany Centre, however expansion plans will include a combination of greenhouse and indoor grow facilities of up to 1 million square feet on the 25 acre farm land acquired in Dewdney Derouche, Mission, BC, Canada.
Terms of the new business partnership will be detailed in a future press release whereby BRIM and Alliance Growers will be working together to finance the construction of the Cannabis Botany Centre facility. The selected property is located at 38482 Bell Road, Dewdney Derouche, Mission, BC and consists of 25.44 acres of land with some of the best water quality in the Greater Fraser Valley. This property has R-3 zoning to be converted to ALR and is located in the Fraser Valley Agricultural Belt, just 75 minutes East of Vancouver. This property is ideal for the Cannabis Botany Centre. Mr. Wojcik, CEO of BRIM, has previously received approval from the municipality under the former Marijuana for Medical Purposes Regulations (“MMPR”) regulations for use in this area on a different project.
Dennis Petke, Alliance Growers’ President and CEO commented “We are very pleased with BRIM’s decision to purchase the land immediately as part of a new partnership to develop the Cannabis Botany Centre. This clears the path for Alliance Growers to close on some of its current financing initiatives and finally begin to execute on this significant portion of its business plan. This is what the team at Alliance Growers and our investors have been waiting for. Getting the ACMPR applicationunderway is a game changer for Alliance Growers as it will advance financing for all of our projects, especially the construction of the facility. I believe that news of the commencement of the ACMPR will make our upcoming RAI$E on the West Coast investor conference and September roadshow a tremendous success.”
The Cannabis Botany Centre will utilize the proprietary Chibafreen Invitro Plant Production System, which assures consistent composition and purity for each plantlet, and proprietary Cryotissue Cold Storage technology. The first Cannabis Botany Centre is the staged development of a 40,000-square foot facility to be in Mission, B.C. The facility will be the first of its kind in Western Canada to include a DNA Botany lab, extraction facility and tissue culture plantlet production facility. The Botany Centre will have the ability to not only service the cannabis market, but other plant-based agricultural markets as well.
The Alliance Growers/BRIM Cannabis Botany Centre will offer customers:
– Disease free, genetically perfect plantlets to growers of all sizes
– Botanical DNA services for certifying plant tissue at the genetic level
– Cold storage technology for tissue culture preservation; and
– Extraction services for CBD oils for retail markets.
Alliance Growers is also pleased to report that the Company has accepted an invitation to participate in the renowned RAI$E on the West Coast Small Cap One-on-One Capital Conference in Vancouver on September 8-9, 2017.
RAI$E is a two-day conference connecting small cap companies and finance professionals and investors for a series of pre-scheduled One-on-One meetings. The conference hosted 20 companies & 20 Investor Groups. Each company meets each Investor Group for a total of 20 meetings, between 9am-4pm. One significant advantage for Alliance Growers is that we will be the only Cannabis Company at the RAI$E conference that was asked to return.
Given the success of the Company’s participation in the RAI$E at the Stampede conference in July, Alliance Growers has decided to kick off its Fall marketing program with the conference. Senior management, including Company CEO and President Dennis Petke, will immediately follow the conference with a two-week road show to pre-set appointments at various destinations across Western Canada.
Commenting on the Company’s participation, Dennis Petke, Alliance Growers’ President and CEO said, “Traditionally the conclusion of the Labour Day weekend brings an enhanced focus on public company corporate activities and marketing efforts. For Alliance Growers, this fall will be a bell weather period for the Company as we begin to bring to fruition the tangible results of our business initiatives as evidenced by the agreement with BRIM for the Cannabis Botany Centre land acquisition. We invite shareholders and potential new investors to watch for exciting announcements over the coming weeks.”
For more information on RAI$E Conferences, visit http://www.raiseconference.com/
About Alliance Growers
Alliance Growers Corp. is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Development.
Alliance Growers is finalizing a new business partnership with Botanical Research In Motion Inc., to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.
Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.
If you would like to be added to Alliance Growers’ news distribution list, please send your email address to [email protected]
On behalf of the board of directors of
ALLIANCE GROWERS CORP.
President and CEO
For more information contact:
Corporate Communications Consultant
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.